T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
WIX.com
WIX
$2.79B
| $394M | 0.07% |
5,490,207
+1,673,520
| +44% | +$111M |
|
|
ELLI
302
DELISTED
Ellie Mae Inc
ELLI
| $392M | 0.07% |
4,771,125
+756,608
| +19% | +$69.4M |
|
303
Western Alliance Bancorporation
WAL
$8.89B
| $392M | 0.07% |
7,381,194
-276,483
| -4% | -$13.6M |
|
304
Mercado Libre
MELI
$98.4B
| $391M | 0.07% |
1,511,801
-1,368,984
| -48% | -$363M |
|
|
PR
305
Permian Resources
PR
$18B
| $391M | 0.07% |
21,917,501
+1,096,613
| +5% | +$18.4M |
|
306
Eli Lilly
LLY
$1.08T
| $391M | 0.07% |
4,570,483
-985,380
| -18% | -$80.8M |
|
307
Marathon Petroleum
MPC
$94.5B
| $390M | 0.07% |
6,960,017
-1,988,984
| -22% | -$107M |
|
|
GGP
308
DELISTED
GGP Inc.
GGP
| $390M | 0.07% |
18,774,642
-189,655
| -1% | -$4.15M |
|
309
Booz Allen Hamilton
BAH
$9.45B
| $388M | 0.07% |
10,380,752
+1,446,962
| +16% | +$49.7M |
|
310
American Water Works
AWK
$27B
| $386M | 0.07% |
4,776,477
+4,221,094
| +760% | +$342M |
|
|
OPLN
311
Openlane
OPLN
$4.48B
| $384M | 0.07% |
21,252,914
+282,438
| +1% | +$4.66M |
|
312
Jefferies Financial Group
JEF
$12.7B
| $378M | 0.06% |
16,728,937
+984,056
| +6% | +$22M |
|
|
BLUE
313
DELISTED
bluebird bio
BLUE
| $376M | 0.06% |
211,268
-14,038
| -6% | -$19.6M |
|
|
ATHN
314
DELISTED
Athenahealth, Inc.
ATHN
| $373M | 0.06% |
2,995,866
-121,173
| -4% | -$16.7M |
|
315
Valmont Industries
VMI
$9.52B
| $373M | 0.06% |
2,356,155
+1,772
| +0.1% | +$267K |
|
316
Kohl's
KSS
$2.1B
| $372M | 0.06% |
8,152,313
-128,897
| -2% | -$5.28M |
|
|
SEM
317
DELISTED
Select Medical
SEM
| $371M | 0.06% |
35,858,193
+859,699
| +2% | +$7.94M |
|
318
Analog Devices
ADI
$188B
| $370M | 0.06% |
4,296,307
+496,240
| +13% | +$40M |
|
319
Douglas Emmett
DEI
$1.92B
| $367M | 0.06% |
9,308,444
+30,785
| +0.3% | +$1.18M |
|
320
Service Corp International
SCI
$11.4B
| $367M | 0.06% |
10,625,145
+92,045
| +0.9% | +$3.19M |
|
321
Molina Healthcare
MOH
$10.2B
| $365M | 0.06% |
5,313,704
+1,721,452
| +48% | +$112M |
|
|
BKI
322
DELISTED
Black Knight, Inc. Common Stock
BKI
| $364M | 0.06% |
8,450,618
+87,487
| +1% | +$3.71M |
|
323
Baxter International
BAX
$14.3B
| $363M | 0.06% |
5,778,507
-137,831
| -2% | -$8.51M |
|
324
Synopsys
SNPS
$78.7B
| $361M | 0.06% |
4,483,544
+677,898
| +18% | +$52.6M |
|
325
Old Dominion Freight Line
ODFL
$43.4B
| $360M | 0.06% |
9,817,077
-2,582,772
| -21% | -$85.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.